{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:38:00Z","timestamp":1790257080062,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,8]],"date-time":"2018-06-08T00:00:00Z","timestamp":1528416000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fondo de Investigaci\u00f3n Sanitaria (FIS) ISCII","award":["PI11\/00462"],"award-info":[{"award-number":["PI11\/00462"]}]},{"DOI":"10.13039\/100008050","name":"Fundaci\u00f3n Cellex","doi-asserted-by":"publisher","award":["CP042187"],"award-info":[{"award-number":["CP042187"]}],"id":[{"id":"10.13039\/100008050","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Centro de Investigacion en Red de Enfermedades Raras"},{"name":"Suports a Grups de Recerca de la Generalitat de Catalunya","award":["893\/2017"],"award-info":[{"award-number":["893\/2017"]}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12967-018-1526-3","type":"journal-article","created":{"date-parts":[[2018,6,8]],"date-time":"2018-06-08T09:06:53Z","timestamp":1528448813000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Exhaustion of mitochondrial and autophagic reserve may contribute to the development of LRRK2\n                G2019S\n              -Parkinson\u2019s disease"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3615-7803","authenticated-orcid":false,"given":"Diana Luz","family":"Ju\u00e1rez-Flores","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Gonz\u00e1lez-Casacuberta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Ezquerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Ba\u00f1\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Carmona-Pontaque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Catal\u00e1n-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariona","family":"Guitart-Mampel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jos\u00e9","family":"Rivero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Tobias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Cesar","family":"Milisenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Tolosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jose","family":"Marti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Fern\u00e1ndez-Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Cardellach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constanza","family":"Mor\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gl\u00f2ria","family":"Garrabou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,8]]},"reference":[{"key":"1526_CR1","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1152\/physrev.00022.2010","volume":"91","author":"O Corti","year":"2011","unstructured":"Corti O, Lesage S, Brice A. What genetics tells us about the causes and mechanisms of Parkinson\u2019s disease. Physiol Rev. 2011;91:1161\u2013218.","journal-title":"Physiol Rev"},{"key":"1526_CR2","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","volume":"7","author":"DG Healy","year":"2008","unstructured":"Healy DG, Falchi M, O\u2019Sullivan SS, Bonifati V, Durr A, Bressman S, et al. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson\u2019s disease: a case-control study. Lancet Neurol. 2008;7:583\u201390.","journal-title":"Lancet Neurol"},{"key":"1526_CR3","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1111\/febs.13305","volume":"282","author":"R Wallings","year":"2015","unstructured":"Wallings R, Manzoni C, Bandopadhyay R. Cellular processes associated with LRRK2 function and dysfunction. FEBS J. 2015;282:2806\u201326.","journal-title":"FEBS J"},{"key":"1526_CR4","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1056\/NEJMc055509","volume":"354","author":"LJ Ozelius","year":"2006","unstructured":"Ozelius LJ, Senthil G, Saunders-Pullman R, Ohmann E, Deligtisch A, Tagliati M, et al. LRRK2 G2019S as a cause of Parkinson\u2019s disease in Ashkenazi Jews. N Engl J. 2006;354:424\u20135.","journal-title":"N Engl J"},{"key":"1526_CR5","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1001\/archneur.63.3.377","volume":"63","author":"C Gaig","year":"2006","unstructured":"Gaig C, Ezquerra M, Marti MJ, Mu\u00f1oz E, Valldeoriola F, Tolosa E. LRRK2 mutations in Spanish patients with Parkinson disease. Arch Neurol. 2006;63:377.","journal-title":"Arch Neurol"},{"key":"1526_CR6","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.parkreldis.2010.08.018","volume":"16","author":"JC D\u00e4chsel","year":"2010","unstructured":"D\u00e4chsel JC, Behrouz B, Yue M, Beevers JE, Melrose HL, Farrer MJ. A comparative study of Lrrk2 function in primary neuronal cultures. Parkinsonism Relat Disord. 2010;16:650\u20135.","journal-title":"Parkinsonism Relat Disord"},{"key":"1526_CR7","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/nn.3350","volume":"16","author":"SJ Orenstein","year":"2013","unstructured":"Orenstein SJ, Kuo S-H, Tasset I, Arias E, Koga H, Fernandez-Carasa I, et al. Interplay of LRRK2 with chaperone-mediated autophagy. Nat Neurosci. 2013;16:394\u2013406.","journal-title":"Nat Neurosci"},{"key":"1526_CR8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s11910-015-0564-y","volume":"15","author":"MR Cookson","year":"2015","unstructured":"Cookson MR. LRRK2 pathways leading to neurodegeneration. Curr Neurol Neurosci Rep. 2015;15:42.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1526_CR9","doi-asserted-by":"publisher","first-page":"e77198","DOI":"10.1371\/journal.pone.0077198","volume":"8","author":"R Migheli","year":"2013","unstructured":"Migheli R, Del Giudice MG, Spissu Y, Sanna G, Xiong Y, Dawson TM, et al. LRRK2 affects vesicle trafficking, neurotransmitter extracellular level and membrane receptor localization. PLoS ONE. 2013;8:e77198.","journal-title":"PLoS ONE"},{"key":"1526_CR10","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.expneurol.2014.05.025","volume":"261","author":"AR Esteves","year":"2014","unstructured":"Esteves AR, Swerdlow RH, Cardoso SM. LRRK2, a puzzling protein: insights into Parkinson\u2019s disease pathogenesis. Exp Neurol. 2014;261:206\u201316.","journal-title":"Exp Neurol"},{"key":"1526_CR11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1146\/annurev-neuro-071013-014317","volume":"37","author":"NA Haelterman","year":"2014","unstructured":"Haelterman NA, Yoon WH, Sandoval H, Jaiswal M, Shulman JM, Bellen HJ. A mitocentric view of Parkinson\u2019s disease. Annu Rev Neurosci. 2014;37:137\u201359.","journal-title":"Annu Rev Neurosci."},{"key":"1526_CR12","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/nm.3232","volume":"19","author":"RA Nixon","year":"2013","unstructured":"Nixon RA. The role of autophagy in neurodegenerative disease. Nat Med. 2013;19:983\u201397.","journal-title":"Nat Med"},{"key":"1526_CR13","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/emmm.201200215","volume":"4","author":"A S\u00e1nchez-Dan\u00e9s","year":"2012","unstructured":"S\u00e1nchez-Dan\u00e9s A, Richaud-Patin Y, Carballo-Carbajal I, Jim\u00e9nez-Delgado S, Caig C, Mora S, et al. Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson\u2019s disease. EMBO Mol Med. 2012;4:380\u201395.","journal-title":"EMBO Mol Med"},{"key":"1526_CR14","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1212\/WNL.0b013e3181ff9685","volume":"75","author":"H Mortiboys","year":"2010","unstructured":"Mortiboys H, Johansen KK, Aasly JO, Bandmann O. Mitochondrial impairment in patients with Parkinson disease with the G2019S mutation in LRRK2. Neurology. 2010;75:2017\u201320.","journal-title":"Neurology"},{"key":"1526_CR15","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1093\/brain\/awt192","volume":"136","author":"JH Kordower","year":"2013","unstructured":"Kordower JH, Olanow CW, Dodiya HB, Chu Y, Beach TG, Adler CH, et al. Disease duration and the integrity of the nigrostriatal system in Parkinson\u2019s disease. Brain. 2013;136:2419\u201331.","journal-title":"Brain"},{"key":"1526_CR16","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/mds.26964","volume":"32","author":"C Pont-Sunyer","year":"2017","unstructured":"Pont-Sunyer C, Tolosa E, Caspell-Garcia C, Coffey C, Alcalay RN, Chan P, et al. The prodromal phase of leucine-rich repeat kinase 2-associated Parkinson disease: clinical and imaging studies. Mov Disord. 2017;32:726\u201338.","journal-title":"Mov Disord"},{"key":"1526_CR17","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1212\/WNL.0000000000001905","volume":"85","author":"H Mortiboys","year":"2015","unstructured":"Mortiboys H, Furmston R, Bronstad G, Aasly J, Elliott C, Bandmann O. UDCA exerts beneficial effect on mitochondrial dysfunction in LRRK2(G2019S) carriers and in vivo. Neurology. 2015;85:846\u201352.","journal-title":"Neurology"},{"key":"1526_CR18","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1212\/WNL.0b013e318227042d","volume":"77","author":"C Marras","year":"2011","unstructured":"Marras C, Schuele B, Munhoz RP, Rogaeva E, Langston JW, Kasten M, et al. Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers. Neurology. 2011;77:325\u201333.","journal-title":"Neurology"},{"key":"1526_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00401-017-1788-5","volume":"135","author":"P Jiang","year":"2017","unstructured":"Jiang P, Dickson DW. Parkinson\u2019s disease: experimental models and reality. Acta Neuropathol. 2017;135:13\u201332.","journal-title":"Acta Neuropathol"},{"key":"1526_CR20","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1111\/j.1742-4658.2012.08516.x","volume":"279","author":"T Alberio","year":"2012","unstructured":"Alberio T, Lopiano L, Fasano M. Cellular models to investigate biochemical pathways in Parkinson\u2019s disease. FEBS J. 2012;279:1146\u201355.","journal-title":"FEBS J"},{"issue":"8","key":"1526_CR21","doi-asserted-by":"publisher","first-page":"5161","DOI":"10.1007\/s12035-015-9435-4","volume":"53","author":"GA Smith","year":"2016","unstructured":"Smith GA, Jansson J, Rocha EM, Osborn T, Hallett PJ, Isacson O. Fibroblast biomarkers of sporadic Parkinson\u2019s disease and LRRK2 kinase inhibition. Mol Neurobiol. 2016;53(8):5161\u201377.","journal-title":"Mol Neurobiol"},{"key":"1526_CR22","doi-asserted-by":"publisher","first-page":"e28536","DOI":"10.1371\/journal.pone.0028536","volume":"6","author":"C Aguer","year":"2011","unstructured":"Aguer C, Gambarotta D, Mailloux RJ, Moffat C, Dent R, McPherson R, et al. Galactose enhances oxidative metabolism and reveals mitochondrial dysfunction in human primary muscle cells. PLoS ONE. 2011;6:e28536.","journal-title":"PLoS ONE"},{"key":"1526_CR23","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1212\/WNL.42.6.1142","volume":"42","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ. What features improve the accuracy of clinical diagnosis in Parkinson\u2019s disease: a clinicopathologic study. Neurology. 1992;42:1142\u20136.","journal-title":"Neurology"},{"key":"1526_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1389200217666160322143631","volume":"17","author":"C Mor\u00e9n","year":"2016","unstructured":"Mor\u00e9n C, Ju\u00e1rez-Flores D, Cardellach F, Garrabou G. The role of therapeutic drugs on acquired mitochondrial toxicity. Curr Drug Metab. 2016;17:1\u20131.","journal-title":"Curr Drug Metab"},{"key":"1526_CR25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/QAD.0000000000000486","volume":"29","author":"C Mor\u00e9n","year":"2015","unstructured":"Mor\u00e9n C, Noguera-Juli\u00e1n A, Garrabou G. Mitochondrial disturbances in HIV pregnancies. Aids. 2015;29:5\u201312.","journal-title":"Aids"},{"key":"1526_CR26","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1097\/QAI.0b013e3181bd564c","volume":"52","author":"G Garrabou","year":"2009","unstructured":"Garrabou G, Mor\u00e9n C, Gallego-Escuredo JM, Milinkovic A, Villarroya F, Negredo E, et al. Genetic and functional mitochondrial assessment of HIV-infected patients developing HAART-related hyperlactatemia. JAIDS J Acquir Immune Defic Syndr. 2009;52:443\u201351.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"1526_CR27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/978-1-61779-382-0_3","volume":"810","author":"D Pesta","year":"2012","unstructured":"Pesta D, Gnaiger E. High-resolution respirometry: OXPHOS protocols for human cells and permeabilized fibers from small biopsies of human muscle. Methods Mol Biol. 2012;810:25\u201358.","journal-title":"Methods Mol Biol"},{"key":"1526_CR28","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3109\/01480545.2013.776578","volume":"36","author":"C Mor\u00e9n","year":"2013","unstructured":"Mor\u00e9n C, Garrabou G, Noguera-Julian A, Rovira N, Catal\u00e1n M, Hern\u00e1ndez S, et al. Study of oxidative, enzymatic mitochondrial respiratory chain function and apoptosis in perinatally HIV-infected pediatric patients. Drug Chem Toxicol. 2013;36:496\u2013500.","journal-title":"Drug Chem Toxicol"},{"key":"1526_CR29","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1042\/CS20160080","volume":"130","author":"M Catal\u00e1n-Garc\u00eda","year":"2016","unstructured":"Catal\u00e1n-Garc\u00eda M, Garrabou G, Mor\u00e9n C, Guitart-Mampel M, Hernando A, D\u00edaz-Ramos \u00c0, et al. Mitochondrial DNA disturbances and deregulated expression of oxidative phosphorylation and mitochondrial fusion proteins in sporadic inclusion body myositis. Clin Sci. 2016;130:1741\u201351.","journal-title":"Clin Sci"},{"key":"1526_CR30","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/cyto.a.20188","volume":"68A","author":"E Lugli","year":"2005","unstructured":"Lugli E, Troiano L, Ferraresi R, Roat E, Prada N, Nasi M, et al. Characterization of cells with different mitochondrial membrane potential during apoptosis. Cytom Part A. 2005;68A:28\u201335.","journal-title":"Cytom Part A"},{"key":"1526_CR31","doi-asserted-by":"publisher","first-page":"4545","DOI":"10.1093\/hmg\/ddt301","volume":"22","author":"Y-C Su","year":"2013","unstructured":"Su Y-C, Qi X. Inhibition of excessive mitochondrial fission reduced aberrant autophagy and neuronal damage caused by LRRK2 G2019S mutation. Hum Mol Genet. 2013;22:4545\u201361.","journal-title":"Hum Mol Genet"},{"key":"1526_CR32","doi-asserted-by":"publisher","first-page":"6896","DOI":"10.1007\/s12035-016-0194-7","volume":"54","author":"MI Alvarez-Mora","year":"2017","unstructured":"Alvarez-Mora MI, Rodriguez-Revenga L, Madrigal I, Guitart-Mampel M, Garrabou G, Mil\u00e0 M. Impaired mitochondrial function and dynamics in the pathogenesis of FXTAS. Mol Neurobiol. 2017;54:6896\u2013902.","journal-title":"Mol Neurobiol"},{"key":"1526_CR33","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9:676\u201382.","journal-title":"Nat Methods"},{"key":"1526_CR34","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s10863-009-9255-1","volume":"41","author":"RK Dagda","year":"2010","unstructured":"Dagda RK, Chu CT. Mitochondrial quality control: insights on how Parkinson\u2019s disease related genes PINK1, parkin, and Omi\/HtrA2 interact to maintain mitochondrial homeostasis. J Bioenerg Biomembr. 2010;41:473\u20139.","journal-title":"J Bioenerg Biomembr"},{"key":"1526_CR35","doi-asserted-by":"publisher","first-page":"585","DOI":"10.4161\/auto.5.5.8823","volume":"5","author":"DC Rubinsztein","year":"2009","unstructured":"Rubinsztein DC, Cuervo AM, Ravikumar B, Sarkar S, Korolchuk V, Kaushik S, et al. In search of an \u201cautophagomometer\u201d. Autophagy. 2009;5:585\u20139.","journal-title":"Autophagy"},{"key":"1526_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15548627.2015.1100356","volume":"12","author":"DJ Klionsky","year":"2016","unstructured":"Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Arozena AA, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 2016;12:1.","journal-title":"Autophagy"},{"key":"1526_CR37","volume-title":"R: a language and environment for computing","author":"R Core Team","year":"2017","unstructured":"R Core Team. R: a language and environment for computing. Vienna: R Foundation for Statistical Computing; 2017."},{"key":"1526_CR38","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1007\/s12035-014-8980-6","volume":"52","author":"AR Esteves","year":"2015","unstructured":"Esteves AR, G-Fernandes M, Santos D, Janu\u00e1rio C, Cardoso SM. The upshot of LRRK2 inhibition to Parkinson\u2019s disease paradigm. Mol Neurobiol. 2015;52:1804\u201320.","journal-title":"Mol Neurobiol"},{"key":"1526_CR39","doi-asserted-by":"publisher","first-page":"4201","DOI":"10.1093\/hmg\/dds244","volume":"21","author":"TD Papkovskaia","year":"2012","unstructured":"Papkovskaia TD, Chau K-Y, Inesta-Vaquera F, Papkovsky DB, Healy DG, Nishio K, et al. G2019S leucine-rich repeat kinase 2 causes uncoupling protein-mediated mitochondrial depolarization. Hum Mol Genet. 2012;21:4201\u201313.","journal-title":"Hum Mol Genet"},{"key":"1526_CR40","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1089\/ars.2013.5737","volume":"20","author":"A Gr\u00fcnewald","year":"2014","unstructured":"Gr\u00fcnewald A, Arns B, Meier B, Brockmann K, Tadic V, Klein C. Does uncoupling protein 2 expression qualify as marker of disease status in LRRK2-associated Parkinson\u2019s disease? Antioxid Redox Signal. 2014;20:1955\u201360.","journal-title":"Antioxid Redox Signal"},{"key":"1526_CR41","doi-asserted-by":"publisher","first-page":"8940","DOI":"10.1523\/JNEUROSCI.0026-12.2012","volume":"32","author":"CN Hall","year":"2012","unstructured":"Hall CN, Klein-Fl\u00fcgge MC, Howarth C, Attwell D. Oxidative phosphorylation, not glycolysis, powers presynaptic and postsynaptic mechanisms underlying brain information processing. J Neurosci. 2012;32:8940\u201351.","journal-title":"J Neurosci"},{"key":"1526_CR42","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1038\/emm.2014.122","volume":"47","author":"M-Y Cha","year":"2015","unstructured":"Cha M-Y, Kim DK, Mook-Jung I. The role of mitochondrial DNA mutation on neurodegenerative diseases. Exp Mol Med. 2015;47:e150.","journal-title":"Exp Mol Med"},{"key":"1526_CR43","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.neuint.2017.03.023","volume":"109","author":"I Lopez-Fabuel","year":"2017","unstructured":"Lopez-Fabuel I, Martin-Martin L, Resch-Beusher M, Azkona G, Sanchez-Pernaute R, Bola\u00f1os JP. Mitochondrial respiratory chain disorganization in Parkinson\u2019s disease-relevant PINK1 and DJ1 mutants. Neurochem Int. 2017;109:101\u20135.","journal-title":"Neurochem Int"},{"key":"1526_CR44","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.tibs.2015.02.003","volume":"40","author":"BJ Ryan","year":"2015","unstructured":"Ryan BJ, Hoek S, Fon EA, Wade-Martins R. Mitochondrial dysfunction and mitophagy in Parkinson\u2019s: from familial to sporadic disease. Trends Biochem Sci. 2015;40:200\u201310.","journal-title":"Trends Biochem Sci"},{"key":"1526_CR45","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/ana.21492","volume":"64","author":"H Mortiboys","year":"2008","unstructured":"Mortiboys H, Thomas KJ, Koopman WJH, Klaffke S, Abou-Sleiman P, Olpin S, et al. Mitochondrial function and morphology are impaired in parkin-mutant fibroblasts. Ann Neurol. 2008;64:555\u201365.","journal-title":"Ann Neurol"},{"key":"1526_CR46","doi-asserted-by":"publisher","first-page":"5256","DOI":"10.1523\/JNEUROSCI.0984-06.2006","volume":"26","author":"PM Keeney","year":"2006","unstructured":"Keeney PM, Xie J, Capaldi RA, Bennett JP. Parkinson\u2019s disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J Neurosci. 2006;26:5256\u201364.","journal-title":"J Neurosci"},{"key":"1526_CR47","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.nbd.2008.06.016","volume":"32","author":"AKF Liou","year":"2008","unstructured":"Liou AKF, Leak RK, Li L, Zigmond MJ. Wild-type LRRK2 but not its mutant attenuates stress-induced cell death via ERK pathway. Neurobiol Dis. 2008;32:116\u201324.","journal-title":"Neurobiol Dis"},{"key":"1526_CR48","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.bbadis.2009.09.013","volume":"1802","author":"B Su","year":"2010","unstructured":"Su B, Wang X, Zheng L, Perry G, Smith MA, Zhu X. Abnormal mitochondrial dynamics and neurodegenerative diseases. Biochim Biophys Acta. 2010;1802:135\u201342.","journal-title":"Biochim Biophys Acta"},{"key":"1526_CR49","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1042\/BST20160265","volume":"45","author":"C Manzoni","year":"2017","unstructured":"Manzoni C. The LRRK2-macroautophagy axis and its relevance to Parkinson\u2019s disease. Biochem Soc Trans. 2017;45:155\u201362.","journal-title":"Biochem Soc Trans"},{"key":"1526_CR50","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00018-012-1061-y","volume":"70","author":"JM Bravo-San Pedro","year":"2013","unstructured":"Bravo-San Pedro JM, Niso-Santano M, G\u00f3mez-S\u00e1nchez R, Pizarro-Estrella E, Aiastui-Pujana A, Gorostidi A, et al. The LRRK2 G2019S mutant exacerbates basal autophagy through activation of the MEK\/ERK pathway. Cell Mol Life Sci. 2013;70:121\u201336.","journal-title":"Cell Mol Life Sci"},{"key":"1526_CR51","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.mcn.2016.06.007","volume":"75","author":"Y Bang","year":"2016","unstructured":"Bang Y, Kim K-S, Seol W, Choi HJ. LRRK2 interferes with aggresome formation for autophagic clearance. Mol Cell Neurosci. 2016;75:71\u201380.","journal-title":"Mol Cell Neurosci"},{"key":"1526_CR52","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.bbrc.2013.10.159","volume":"441","author":"C Manzoni","year":"2013","unstructured":"Manzoni C, Mamais A, Dihanich S, McGoldrick P, Devine MJ, Zerle J, et al. Pathogenic Parkinson\u2019s disease mutations across the functional domains of LRRK2 alter the autophagic\/lysosomal response to starvation. Biochem Biophys Res Commun. 2013;441:862\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"1526_CR53","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.4161\/15548627.2014.973338","volume":"10","author":"B Loos","year":"2014","unstructured":"Loos B, du Toit A, Hofmeyr J-HS. Defining and measuring autophagosome flux\u2014concept and reality. Autophagy. 2014;10:2087\u201396.","journal-title":"Autophagy"},{"key":"1526_CR54","doi-asserted-by":"publisher","first-page":"214.e1","DOI":"10.1016\/j.neurobiolaging.2015.10.026","volume":"38","author":"J Infante","year":"2016","unstructured":"Infante J, Prieto C, Sierra M, S\u00e1nchez-Juan P, Gonz\u00e1lez-Aramburu I, S\u00e1nchez-Quintana C, et al. Comparative blood transcriptome analysis in idiopathic and LRRK2 G2019S-associated Parkinson\u2019s disease. Neurobiol Aging. 2016;38:214.e1\u20135.","journal-title":"Neurobiol Aging."},{"key":"1526_CR55","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.parkreldis.2008.06.008","volume":"15","author":"E Lohmann","year":"2009","unstructured":"Lohmann E, Leclere L, De Anna F, Lesage S, Dubois B, Agid Y, et al. A clinical, neuropsychological and olfactory evaluation of a large family with LRRK2 mutations. Parkinsonism Relat Disord. 2009;15:273\u20136.","journal-title":"Parkinsonism Relat Disord"},{"key":"1526_CR56","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1002\/mds.23991","volume":"26","author":"K Brockmann","year":"2011","unstructured":"Brockmann K, Gr\u00f6ger A, Di Santo A, Liepelt I, Schulte C, Klose U, et al. Clinical and brain imaging characteristics in leucine-rich repeat kinase 2-associated PD and asymptomatic mutation carriers. Mov Disord. 2011;26:2335\u201342.","journal-title":"Mov Disord"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-018-1526-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-018-1526-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-018-1526-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T19:14:04Z","timestamp":1559934844000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-018-1526-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,8]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1526"],"URL":"https:\/\/doi.org\/10.1186\/s12967-018-1526-3","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,8]]},"assertion":[{"value":"8 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"160"}}